Skip to main content

Market Research Outlook

MRO Tracker · Pharma

Monthly count of drug samples declared not of standard quality or spurious by central and state drug testing laboratories. Updated each month when the national alert is released.

330samples failed in September 2026
+50%on August 2026 (220)
288flagged by state laboratories
1spurious sample, from Delhi
MRO View: September 2026 was the highest monthly count in this tracker, driven by state laboratories. A failed sample relates to that batch only, and companies often dispute that flagged batches were theirs, so counts point to testing intensity as much as to quality.

Monthly alerts

Drug samples found not of standard quality, by month
September 2026330
August 2026220
May 2026159
October 2025211
MonthCentral labsState labsTotal not of standard qualitySpurious
September 2026422883301 (Delhi)
August 2026291912201 (Delhi)
May 2026461131591 (Assam)
October 2025631482115 (3 Bihar, 2 Delhi)

A sample is not of standard quality when it fails one or more specified quality parameters. Spurious drugs are made by unauthorised manufacturers using another company’s brand name.

Need the numbers behind this tracker?

We assess supplier quality risk and brand exposure for pharma and healthcare clients.

Get the monthly India tracker updateNew state data and new plant announcements in one short email, once a month.

One email a month. Reply to any email to unsubscribe. Privacy policy